Kortikotropin-oslobađajući hormonski receptor 1
Изглед
Kortikotropin-oslobađajući hormonski receptor 1 (CRHR1, CRF1) je protein koji je kod ljudi kodiran CRHR1 genom.[1][2][3]
Funkcija
[уреди | уреди извор]Kortikotropin-oslobađajući hormonski receptor vezuje kortikotropin-oslobađajući hormon, potentan posrednik endokrinog, autonomnog, i imunskog responsa na stres.[4]
Kod miševa CRF1 receptori posreduju etanolno pojačanje GABAergične sinaptičke transmisije.[5]
Klinički značaj
[уреди | уреди извор]Varijacije CRHR1 gena su povezane za povećanjem odgovora na inhalacionu kortikosteroidnu terapiju kod astme.[6] Antagonisti CRF1 receptora se aktivno ispituju kao mogući tretman za depresiju i anksioznost.[7][8]
Interakcije
[уреди | уреди извор]Za kortikotropin-oslobađajući hormonski receptor 1 je pokazano da interaguje sa kortikotropin-oslobađajućim hormonom[9][10] i urokortinom.[10][11]
Vidi još
[уреди | уреди извор]- Kortikotropin-oslobađajući hormon
- Kortikotropin-oslobađajući hormonski receptor
- Kortikotropin-oslobađajući hormonski antagonisti
- Antalarmin
Reference
[уреди | уреди извор]- ^ Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (2003). „International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands”. Pharmacol. Rev. 55 (1): 21—6. PMID 12615952. doi:10.1124/pr.55.1.3.
- ^ Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH (1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22”. Genomics. 28 (1): 123—4. PMID 7590738. doi:10.1006/geno.1995.1118.
- ^ Chen R, Lewis KA, Perrin MH, Vale WW (1993). „Expression cloning of a human corticotropin-releasing-factor receptor”. Proc. Natl. Acad. Sci. U.S.A. 90 (19): 8967—71. PMC 47482 . PMID 7692441. doi:10.1073/pnas.90.19.8967.
- ^ „Entrez Gene: CRHR1 corticotropin releasing hormone receptor 1”.
- ^ Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR (2004). „Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors”. Science (journal). 303 (5663): 1512—4. PMID 15001778. doi:10.1126/science.1092550.
- ^ Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, Liggett SB, Gelfand EW, Rosenwasser LJ, Richter B, Israel E, Wechsler M, Gabriel S, Altshuler D, Lander E, Drazen J, Weiss ST (2004). „Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids”. Hum. Mol. Genet. 13 (13): 1353—9. PMID 15128701. doi:10.1093/hmg/ddh149.
- ^ Kehne JH (2007). „The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders”. CNS Neurol Disord Drug Targets. 6 (3): 163—82. PMID 17511614. doi:10.2174/187152707780619344.
- ^ Ising M, Holsboer F (2007). „CRH-sub-1 receptor antagonists for the treatment of depression and anxiety”. Exp Clin Psychopharmacol. 15 (6): 519—28. PMID 18179304. doi:10.1037/1064-1297.15.6.519.
- ^ Grammatopoulos, D K; Dai Y; et al. (1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. UNITED STATES. 13 (12): 2189—202. ISSN 0888-8809. PMID 10598591. doi:10.1210/me.13.12.2189.
- ^ а б Gottowik, J; Goetschy V; et al. (1997). „Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin”. Neuropharmacology. ENGLAND. 36 (10): 1439—46. ISSN 0028-3908. PMID 9423932. doi:10.1016/S0028-3908(97)00098-1.
- ^ Donaldson, C J; Sutton S W; et al. (1996). „Cloning and characterization of human urocortin”. Endocrinology. UNITED STATES. 137 (5): 2167—70. ISSN 0013-7227. PMID 8612563. doi:10.1210/en.137.5.2167.
Literatura
[уреди | уреди извор]- Taché Y, Martinez V, Wang L, Million M (2004). „CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.”. Br. J. Pharmacol. 141 (8): 1321—30. PMC 1574904 . PMID 15100165. doi:10.1038/sj.bjp.0705760.
- McLean M; Bisits A; Davies J; et al. (1995). „A placental clock controlling the length of human pregnancy.”. Nat. Med. 1 (5): 460—3. PMID 7585095. doi:10.1038/nm0595-460.
- Polymeropoulos MH; Torres R; Yanovski JA; et al. (1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22.”. Genomics. 28 (1): 123—4. PMID 7590738. doi:10.1006/geno.1995.1118.
- Chen R, Lewis KA, Perrin MH, Vale WW (1993). „Expression cloning of a human corticotropin-releasing-factor receptor.”. Proc. Natl. Acad. Sci. U.S.A. 90 (19): 8967—71. PMC 47482 . PMID 7692441. doi:10.1073/pnas.90.19.8967.
- Ross PC, Kostas CM, Ramabhadran TV (1995). „A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.”. Biochem. Biophys. Res. Commun. 205 (3): 1836—42. PMID 7811272. doi:10.1006/bbrc.1994.2884.
- Opdenakker G; Fiten P; Nys G; et al. (1994). „The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12.”. Genomics. 21 (2): 403—8. PMID 7916328. doi:10.1006/geno.1994.1283.
- Vita N; Laurent P; Lefort S; et al. (1993). „Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors.”. FEBS Lett. 335 (1): 1—5. PMID 8243652. doi:10.1016/0014-5793(93)80427-V.
- Donaldson CJ; Sutton SW; Perrin MH; et al. (1996). „Cloning and characterization of human urocortin.”. Endocrinology. 137 (5): 2167—70. PMID 8612563. doi:10.1210/en.137.5.2167.
- Liaw CW; Grigoriadis DE; Lovenberg TW; et al. (1997). „Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach.”. Mol. Endocrinol. 11 (7): 980—5. PMID 9178757. doi:10.1210/me.11.7.980.
- Asakura H, Zwain IH, Yen SS (1997). „Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary.”. J. Clin. Endocrinol. Metab. 82 (8): 2720—5. PMID 9253360. doi:10.1210/jc.82.8.2720.
- Gottowik J; Goetschy V; Henriot S; et al. (1998). „Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.”. Neuropharmacology. 36 (10): 1439—46. PMID 9423932. doi:10.1016/S0028-3908(97)00098-1.
- Grammatopoulos D; Dai Y; Chen J; et al. (1998). „Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria.”. J. Clin. Endocrinol. Metab. 83 (7): 2539—44. PMID 9661640. doi:10.1210/jc.83.7.2539.
- Sakai K; Yamada M; Horiba N; et al. (1998). „The genomic organization of the human corticotropin-releasing factor type-1 receptor.”. Gene. 219 (1-2): 125—30. PMID 9757017. doi:10.1016/S0378-1119(98)00322-9.
- Grammatopoulos DK; Dai Y; Randeva HS; et al. (2000). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.”. Mol. Endocrinol. 13 (12): 2189—202. PMID 10598591. doi:10.1210/me.13.12.2189.
- Lewis K; Li C; Perrin MH; et al. (2001). „Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.”. Proc. Natl. Acad. Sci. U.S.A. 98 (13): 7570—5. PMC 34709 . PMID 11416224. doi:10.1073/pnas.121165198.
- Perrin MH; Fischer WH; Kunitake KS; et al. (2001). „Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor.”. J. Biol. Chem. 276 (34): 31528—34. PMID 11425856. doi:10.1074/jbc.M101838200.
- Pisarchik A, Slominski AT (2002). „Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression.”. FASEB J. 15 (14): 2754—6. PMID 11606483. doi:10.1096/fj.01-0487fje.
- Graziani G; Tentori L; Portarena I; et al. (2002). „CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway.”. Endocrinology. 143 (3): 807—13. PMID 11861501. doi:10.1210/en.143.3.807.
- Strausberg RL; Feingold EA; Grouse LH; et al. (2003). „Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899—903. PMC 139241 . PMID 12477932. doi:10.1073/pnas.242603899.
- King JS, Bishop GA (2003). „The distribution and cellular localization of CRF-R1 in the vermis of the postnatal mouse cerebellum.”. Exp. Neurol. 178 (2): 175—85. PMID 12504877. doi:10.1006/exnr.2002.8052.
Spoljašnje veze
[уреди | уреди извор]- „Corticotropin-releasing Factor Receptors: CRF1”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Архивирано из оригинала 20. 11. 2015. г.
- CRF+receptor+type+1 на US National Library of Medicine Medical Subject Headings (MeSH)